Sign up for our eNews and discover more about what we're up to, the difference we're making, and, most importantly, how you can help.
Friday 14 December 2018
The Dementia Australia Research Foundation, with the Yulgilbar Alzheimer’s Research Program (YARP), have announced three, rather than one, recipients of its inaugural $1 Million Dollar Innovation Grant for new research ideas that advance dementia research.
Dementia Australia Research Foundation Chair, Professor Graeme Samuel AC, said that submissions to the inaugural $1 Million Innovation Grant so inspired the judging panel and funders that an additional $1 million would be shared between two runner-up projects.
“Dementia Australia is thrilled to see the Grant attract a brilliant cross-pollination of internationally-recognised scientists and researchers across areas of nanoscience, stem-cell biology and health data,” Professor Samuel said.
A $1 million grant has been awarded to Professor Perminder Sachdev, of UNSW Sydney’s Centre for Healthy Brain Ageing while two new $500,000 Grants have been awarded to Professor Simon Bell at the Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, and Professor Chennupati Jagadish AC from the Australian National University.
The Yulgilbar Alzheimer’s Research Program’s Scientific Director, Professor Bob Williamson, said the judging panel assessed all the submissions for their novelty and innovation, links to people living with dementia, families and carers, and the extent to which they would be developing and introducing new and younger researchers into the dementia field.
“I congratulate Professor Sachdev and his team, who propose to use nanoparticles to move across the blood brain barrier and target dementia-specific molecules in the brain such as amyloid and tau,” Professor Williamson said.
“This offers a chance of better, more rapid and accurate diagnosis, and in the long run the team hope to show that the nanoparticles may be used to piggy-back drugs into the brain to delay or treat dementia.”
Runner-up recipient Professor Bell with colleagues from the United States, United Kingdom and Hong Kong, will evaluate health data from hundreds of thousands of patients.
“Using modern big data and public health techniques, Professor Bell will be able to work out which drugs to use to support people with dementia, and perhaps allow personalised medicine approaches that use individual data to predict the best response, something that is only possible with international collaboration,” Professor Williamson said.
In a world first, the second runner-up recipient, Professor Jagadish, will combine technologies in stem cell research with artificial intelligence (AI) to develop ‘brain organoids’ or ‘mini-brains’ from stem cells taken from people living with Alzheimer’s disease as well as individuals unaffected by the disease.
“Professor Jagadish and his team will model brain function ‘in-the-dish’ and then apply computational and AI-based analyses to identify key functional differences between normal and Alzheimer’s disease brain organoids and predict stimulation parameters that may promote ‘normal’ brain function,” Professor Williamson said.
Each of the successful projects will include vital input from people living with dementia and carers throughout all stages of the research process.
John Quinn, aged 67, who is living with dementia, said the inclusion of people living with dementia and carers at this level of research is key to the authenticity and credibility of each project and ultimately, leads to better quality health outcomes.
“These projects demonstrate how dementia research can be a partnership between researchers, clinicians, people living with dementia, and if appropriate, care partners and family,” Mr Quinn said.
Commitment to research aimed at preventing and treating all forms of dementia, and especially Alzheimer’s disease, has grown both in size and substance during the past five years.
“In 2013 the Australian Government allocated $200 million to the Boosting Dementia Research Initiative which has been crucial to creating momentum in Australia and positioning our researchers on the world stage,” Professor Samuel said.
“These new grants, coming from the Dementia Australia Research Foundation, represent a truly exciting development in the funding of internationally-significant dementia research, which has been achieved through a collaborative partnership of philanthropic organisations that have a shared vision for research in Australia.
“With more than 40 high-calibre separate bids for these grants, our Innovation Grant has clearly demonstrated the numbers of Australian doctors and scientists keen to get involved in dementia research.
“I call on all governments and philanthropists to consider how they too can expand research into dementia in Australia and make a difference to the lives of all people impacted by dementia now and for the generations to come.”
For more information go to Dementia Australia Research Foundation dementia.org.au/research.
- Ends –
The Dementia Australia Research Foundation is the research arm of Dementia Australia. The Foundation provides funding to support new and emerging dementia researchers, and works with consumers to ensure that research reflects their concerns and it promotes understanding and awareness of dementia research among the community. The Foundation is entirely funded by donations and support from members of the public and Australian businesses and is managed by Dementia Australia Limited.
Further information about the Foundation including previous grant rounds and outcomes can be found at: https://www.dementia.org.au/research.
The Yulgilbar Foundation was established in 2001 as a philanthropic foundation. In 2014, it commenced a special program of research grants named the Yulgilbar Alzheimer’s Research Program (YARP). Their mission is to assist in supporting discoveries that will prevent, delay the onset, slow down the progress and ultimately, cure Alzheimer’s disease.
National Dementia Helpline 1800 100 500 | Interpreter service available | Dementia is a National Health Priority Area
The National Dementia Helpline is funded by the Australian Government
Media contacts: Christine Bolt 0400 004 553, [email protected] / Professor Bob Williamson, 0409 706 255
When talking or writing about dementia please refer to Dementia Language Guidelines.
More media releases
Ita Buttrose AC OBE encourages aged care sector to join free dementia webinars
Dementia Australia’s National Ambassador Ita Buttrose AC OBE has invited aged care professionals to register for the Dementia Australia National Symposium Series 2020 – Dementia care is quality care. Ms Buttrose said she will present at the final session of the online weekly webinar series, which will be held for six consecutive weeks starting Tuesday 4 August.
Back on the bike to raise money for support and a cure for dementia
The Bondi2Berry charity bike ride is back this September and aiming to raise $100,000 for Dementia Australia. Dementia is the second leading cause of death of Australians and the leading cause of death among women and in 2020, there are an estimated 459,000 Australians living with the condition. The Bondi2Berry ride has raised more than $500,000 for Dementia Australia since its inception and this money has gone towards supporting people impacted by dementia and vital research into a cure.
Dementia Australia National Symposium moves to free webinar series
Originally planned to be held in Sydney earlier this year, the ‘Dementia Australia National Symposium Series 2020 – Dementia care is quality care’ has now been transformed into an online series of virtual events. Dementia Australia CEO Maree McCabe said the 90-minute weekly online webinar series will be held over six weeks beginning on Tuesday 4 August.